A prototype Protein A resin is evaluated for purification performance, reusability, and cost performance.
Shohei Kobayashi
Advertisement
Shohei Kobayashi is in the API process development department, Pharmaceutical Technology Division, Chugai Pharmaceutical, Tokyo, Japan.
Articles by Shohei Kobayashi
Advertisement
Latest Updated Articles
Comparing Protein A Resins for Monoclonal Antibody PurificationDecember 1st 2013
Advertisement
Advertisement